Related Experiment Video
Updated: Jul 16, 2026

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Multicenter evaluation of a rapid electrochemiluminescent adrenocorticotropic hormone (ACTH) immunoassay
Inge Verschraegen1, Ellen Anckaert, Johan Schiettecatte
1Laboratory of Radioimmunology, Dutch-speaking Free University of Brussels (AZ-VUB), Laarbeeklaan 101, B-1090 Brussels, Belgium.
Background:
Measuring plasma adrenocorticotropic hormone (ACTH) is a key step in the differential diagnosis of hypothalamic-pituitary-adrenal disorders.
Methods:
The recently developed electrochemiluminescence Elecsys ACTH immunoassay (Roche Diagnostics, Mannheim, Germany) was evaluated at six clinical laboratories on the Modular E170 and/or the Elecsys 2010 (Roche Diagnostics) immunoanalysers.
Results:
The within-run and between-run imprecision was
Conclusion:
The non-isotopic Elecsys ACTH immunoassay provides precision and reliability in combination with reduced turnaround time.

